Carlsten et al. further reported the loss of the potent anti-tumor property of NK cells in vitro and that these NK cells display impaired cytotoxicity towards CD34+ MDS blast cells, hence evading tumor surveillance. The gene discussed is CD34; the disease is neoplasm.